Prospera Financial Services’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,185
Closed -$628K 1428
2025
Q4
$628K Buy
31,185
+6,430
+26% +$93.8K 0.01% 848
2025
Q3
$214K Buy
+24,755
New +$177K ﹤0.01% 1282

Other funds holding BNR

Prospera Financial Services's BNR Position: Q1 2026 in Review

Prospera Financial Services sold out of Burning Rock Biotech (BNR) in Q1 2026, closing a stake of 31,185 shares — an estimated $628K sold.

Prospera Financial Services first reported a position in BNR in Q3 2025 and held it in 2 quarters. The position peaked at $628K in Q4 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Prospera Financial Services reported no remaining Burning Rock Biotech position as of Q1 2026 after selling out during the quarter.
  • Prospera Financial Services sold 31,185 Burning Rock Biotech shares in Q1 2026, an estimated $628K.
  • Prospera Financial Services first reported a position in Burning Rock Biotech in Q3 2025 and held it in 2 quarters.
  • Prospera Financial Services's Burning Rock Biotech position peaked at $628K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Prospera Financial Services's 13F filing for Q1 2026, filed 14 Apr 2026.